Invest now

Zydus Lifesciences Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -
1,142.75 -10.75 (-0.93%)Updated : 17 Jul 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Issuance( Retirement)of Debt Net 7,266.802,406.20-391.50-3,143.90
Net Changein Cash 28.40413.80-74.80-170.00
Cash Taxes Paid 1,591.001,801.901,285.80592.00
Net Income/ Starting Line 6,621.106,026.704,808.902,589.70
Total Cash Dividends Paid -1,106.30-302.50-621.00-267.10
Changesin Working Capital -4,024.50-253.80-2,182.50-827.80
Cashfrom Operating Activities 2,306.806,793.303,202.302,688.80
Cash Interest Paid 353.60---
Cashfrom Financing Activities 5,806.902,014.20-1,778.80-4,400.40
Depreciation/ Depletion 1,408.00915.80764.10722.70
Other Investing Cash Flow Items Total -4,902.10-6,659.70-568.602,565.90
Capital Expenditures -3,394.00-1,712.60-906.60-1,030.90
period Type ----
Foreign Exchange Effects 210.80-21.40-23.106.60
Non- Cash Items -1,697.80104.60-188.20204.20
Financing Cash Flow Items -353.60-89.50-41.30-126.20
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -8,296.10-8,372.30-1,475.201,535.00
Issuance( Retirement)of Stock Net -0.00-725.00-863.20
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,570.50+59.15(3.91%)
2,840.00-19.55 (-0.68%)